Acadia Healthcare (ACHC) Agrees to $17M Settlement Amid Legal Scrutiny
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2h ago
0mins
Source: NASDAQ.COM
- Legal Troubles Intensify: Acadia Healthcare faces multiple subpoenas from the DOJ and SEC following a New York Times article alleging patient coercion for profit, leading to increased legal costs that threaten financial stability.
- Financial Strain Evident: The company's adjusted EPS guidance for 2025 has been lowered to between $2.35 and $2.45, down from $2.45 to $2.65, indicating ongoing financial pressures and declining profitability.
- Rising Costs Impact: Total expenses surged 15% year-over-year due to rising wages, benefits, and supply prices, further squeezing margins and suggesting negative growth prospects in the coming quarters.
- Weak Stock Performance: ACHC shares have plummeted 64.53% year-to-date, significantly underperforming major market indices, reflecting pronounced technical weakness and market pessimism regarding future growth prospects.
ACHC
$14.46+Infinity%1D
Analyst Views on ACHC
Wall Street analysts forecast ACHC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ACHC is 25.56 USD with a low forecast of 17.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
7 Buy
3 Hold
0 Sell
Moderate Buy
Current: 14.410
Low
17.00
Averages
25.56
High
30.00
Current: 14.410
Low
17.00
Averages
25.56
High
30.00
About ACHC
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services across the United States. It provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. Its comprehensive treatment centers specialize in providing medication-assisted treatment in an outpatient setting. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. The facilities balance therapy activities with social, academic and other activities. It operates a network of 262 behavioral healthcare facilities with over 11,850 beds in 39 states and Puerto Rico.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
